Metabolic effects of long-term thiazolidinedione treatment in insulin resistance

Abstract

Long-term pioglitazone treatment of rats ameliorates dyslipidemia and insulin resistance in muscle and adipose tissue. Gradual decrease in serum insulin levels during therapy suggest positive effects on hyperinsulinemia and a possibilty to prevent type 2 diabete